Synovial chondromatosis of the temporomandibular joint: clinical and immunohistopathological considerations.

A histopathological study of 30 cases of synovial osteochondromatosis found that the process followed a temporal sequence characterised by three phases: (I) active intrasynovial disease only; (II) transitional lesions with both active intrasynovial proliferation and free loose bodies; and (III) many free osteochondral bodies with no demonstrable intrasynovial disease [J. Bone Joint Surg. 59 (1977) 792]. We present five cases of synovial chondromatosis of the temporpmandibular joint (TMJ) which we studied by immunohistochemical methods of for transforming growth factor beta (TGFbeta) and tenascin.
AuthorsS Fujita, H Yoshida, I Tojyo, T Wada, K Murakami, T Iizuka
JournalThe British journal of oral & maxillofacial surgery (Br J Oral Maxillofac Surg) Vol. 42 Issue 3 Pg. 259-60 (Jun 2004) ISSN: 0266-4356 [Print] Scotland
PMID15121276 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Tenascin
  • Transforming Growth Factor beta
  • Adult
  • Chondromatosis, Synovial (pathology)
  • Female
  • Humans
  • Immunohistochemistry
  • Joint Loose Bodies (pathology)
  • Temporomandibular Joint Disorders (pathology)
  • Tenascin (analysis)
  • Transforming Growth Factor beta (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: